StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
631
This month
10
This week
4
This year
59
Yesterday
1
Publishing Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 19
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
5
2023 - 04 - 12
3
2023 - 03 - 28
4
2023 - 03 - 10
4
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 08
3
2023 - 01 - 11
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 29
3
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
3
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 10 - 27
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Sector
Communications
6
Consumer durables
1
Consumer non-durables
13
Electronic technology
2
Finance
6
Finance and insurance
1
Health services
1
Health technology
631
Manufacturing
65
Mining, quarrying, and oil and gas extraction
1
N/a
122
Process industries
14
Producer manufacturing
9
Professional, scientific, and technical services
3
Retail trade
2
Technology services
1
Tags
Active
10
Agreement
8
Ajovy
8
Alzheimer's
9
America
38
Application
11
Approval
13
Asia
13
Austedo
9
Avt02
11
Avt04
11
Biosimilar
41
Business
12
Cancer
21
Children
18
Clinical-trials-phase-iii
8
Collaboration
9
Conference
20
Dermatitis
8
Disease
36
Drug
44
Dupixent
34
Earnings
14
Europe
15
Events
10
Expected
12
Fda
22
Financial
21
Global
111
Growing
17
Growth
133
Health
11
Libtayo
8
License
11
Liver
8
Market
313
Migraine
9
N/a
514
Pharm-country
18
Pharma
11
Pharmaceuticals
9
Phase 3
15
Positive
14
Reach
16
Report
95
Research
59
Respiratory
10
Results
47
Review
8
Set
12
Stelara
12
Study
20
System
11
Teva
53
Therapeutics
64
Therapy
14
Treatment
76
Trial
12
Update
20
Year
8
Entities
3m company
9
Abbott laboratories
43
Abbvie inc.
129
Acadia pharmaceuticals inc.
3
Adc therapeutics sa
3
Albemarle corporation
8
Alcon inc.
4
Alkermes plc
5
Alnylam pharmaceuticals, inc.
4
Alvotech lux holdings s.a.s.
83
Amgen inc.
83
Antares pharma, inc.
4
Aptargroup, inc.
5
Astellas pharma inc
27
Astrazeneca plc
85
Avadel pharmaceuticals plc
4
Bausch health companies inc.
33
Baxter international inc.
25
Becton, dickinson and company
4
Biogen inc.
28
Bristol-myers squibb company
37
Checkmate pharmaceuticals, inc.
4
Csl ltd
6
Cti biopharma corp.
4
Denali therapeutics inc.
5
Eli lilly and company
61
Endo international plc
28
Galapagos nv
3
Gilead sciences, inc.
10
Glaxosmithkline plc
147
Grifols sa
4
Icon plc
3
Intellia therapeutics, inc.
6
Ionis pharmaceuticals, inc.
4
Jazz pharmaceuticals plc
8
Johnson & johnson
80
Kamada ltd.
85
Koninklijke philips n.v.
12
Mallinckrodt plc
15
Medtronic plc
9
Morgan stanley
5
Neurocrine biosciences, inc.
3
Novartis ag
206
Novo nordisk a/s
15
Obseva sa
3
Orange
6
Perrigo company
6
Pfizer, inc.
29
Prestige consumer healthcare inc.
4
Puma biotechnology inc
4
Reckitt benckiser group plc
11
Regeneron pharmaceuticals, inc.
72
Sanofi
224
Takeda pharmaceutical company limited
20
Taro pharmaceutical industries ltd.
5
Teva pharmaceutical industries limited
64
Teva pharmaceutical industries ltd
631
Thermo fisher scientific inc
8
Ucb s.a.
7
Viatris inc.
102
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Nasdaq
631
Nyse
434
Crawled Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2024 - 01 - 19
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
6
2023 - 03 - 28
4
2023 - 03 - 10
3
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
4
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 11 - 25
2
2021 - 11 - 12
2
2021 - 11 - 04
2
2021 - 10 - 27
3
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 14
2
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Crawled Time
00:00
32
00:20
6
01:00
17
02:00
12
03:00
14
04:00
9
04:20
5
05:00
10
06:00
16
07:00
16
08:00
25
08:20
1
09:00
43
10:00
24
11:00
23
12:00
44
12:15
1
12:20
9
12:30
3
13:00
36
13:20
8
13:30
7
14:00
19
14:20
2
14:30
5
15:00
21
15:20
1
15:30
9
16:00
26
16:20
4
17:00
23
18:00
24
19:00
23
20:00
21
20:20
4
21:00
24
22:00
30
23:00
34
Source
ir.biolinerx.com
1
ir.vtvtherapeutics.com
1
www.biospace.com
117
www.globenewswire.com
95
www.prnewswire.com
417
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
TEVJF
save search
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.77%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-4.74%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.43%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
1.69%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
0.9%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.9%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$5.01
0.4%
0.4%
290K
|
Health Technology
|
5.14%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.01%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-14.52%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
Published:
2024-01-30
(Crawled : 12:00)
- prnewswire.com
TARO
|
$42.25
0.14%
0.0%
17K
|
Health Technology
|
-1.93%
|
O:
-0.07%
H:
1.68%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-7.15%
|
O:
0.05%
H:
0.05%
C:
-1.31%
management
At 3.7% CAGR, Global Carboprost Tromethamine Market Size Value to be Worth USD 2,100.63 Million By 2032: Polaris Market Research
Published:
2024-01-29
(Crawled : 15:30)
- prnewswire.com
ZTS
|
News
|
$146.5
-4.32%
0.0%
6.2M
|
Health Technology
|
-23.51%
|
O:
-0.08%
H:
0.86%
C:
0.73%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
1.75%
|
O:
-0.46%
H:
1.97%
C:
1.22%
million
research
global
market
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published:
2024-01-29
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-9.76%
|
O:
2.39%
H:
4.67%
C:
1.67%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-9.58%
|
O:
-1.05%
H:
0.41%
C:
-0.35%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-13.74%
|
O:
-0.11%
H:
0.7%
C:
0.65%
avt03
prolia
biosimilar
positive
results
study
Ibuprofen API Market Records Growth of USD 31.68 million from 2022 to 2027, Major Innovations and Key Vendor Offerings - Technavio
Published:
2024-01-23
(Crawled : 10:00)
- prnewswire.com
MNKPF
|
$17.25
|
n/a
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
million
key
growth
market
Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published:
2024-01-23
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
0.5%
|
O:
-2.34%
H:
0.43%
C:
0.43%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-0.06%
|
O:
-2.16%
H:
1.17%
C:
1.17%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-13.7%
|
O:
0.46%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-3.35%
|
O:
0.17%
H:
1.33%
C:
0.94%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-13.01%
|
O:
-0.96%
H:
0.3%
C:
0.28%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
0.56%
|
O:
-0.76%
H:
0.38%
C:
0.13%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
1.38%
|
O:
0.37%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.66%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-9.45%
|
O:
-2.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.1%
|
O:
-1.27%
H:
0.8%
C:
0.69%
drug
hospital
infection
therapeutics
growth
market
Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva Pharma, 3M Company, Nitto Denko Corporation, and Johnson & Johnson
Published:
2024-01-19
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-12.65%
|
O:
-0.19%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-0.18%
|
O:
0.0%
H:
1.42%
C:
1.15%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.65%
|
O:
-0.44%
H:
0.64%
C:
0.63%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.52%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-6.06%
|
O:
-0.24%
H:
0.0%
C:
0.0%
MMM
|
$92.27
0.86%
-0.18%
3.6M
|
Producer Manufacturing
|
-13.31%
|
O:
0.28%
H:
1.52%
C:
0.96%
transdermal
global
teva
skin
market
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
Published:
2024-01-19
(Crawled : 17:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
7.79%
|
O:
6.64%
H:
11.54%
C:
8.1%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-11.73%
|
O:
-0.85%
H:
1.46%
C:
0.69%
avt02
avt04
license
update
European Patent Office Rules in Favor of Exelixis on Formulation Patent Covering CABOMETYX® (cabozantinib) Tablets
Published:
2024-01-18
(Crawled : 00:00)
- biospace.com/
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-0.09%
|
O:
-0.31%
H:
0.0%
C:
-0.89%
cabometyx
patent
2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published:
2024-01-17
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-12.65%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.84%
|
O:
-0.78%
H:
0.59%
C:
0.57%
VRNA
|
$15.82
-1.74%
-1.83%
640K
|
Health Technology
|
-8.82%
|
O:
0.52%
H:
2.31%
C:
-0.87%
NKTR
|
News
|
$1.265
-4.17%
-4.35%
4.7M
|
Health Technology
|
151.22%
|
O:
-0.73%
H:
12.24%
C:
12.24%
companies
report
pipeline
research
key
Paracetamol Market to grow by USD 791.9 million from 2022 to 2027, North America accounts for 37% of market growth- Technavio
Published:
2024-01-17
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
3.11%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-0.33%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.39%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
million
market
Global Erectile Dysfunction Drugs Market Research Report 2024: Novel Drug Launches Propel Growth, Growing Geriatric Population Drives Demand - Forecast to 2034
Published:
2024-01-16
(Crawled : 00:00)
- prnewswire.com
MGRX
|
$0.286
-4.64%
-4.86%
78K
|
|
-4.92%
|
O:
3.28%
H:
4.38%
C:
-0.19%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-12.55%
|
O:
-2.03%
H:
0.05%
C:
0.05%
PTPI
|
$0.6849
-1.86%
-1.9%
150K
|
|
-49.05%
|
O:
0.38%
H:
0.0%
C:
-7.58%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
12.97%
|
O:
0.15%
H:
0.59%
C:
-1.45%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.59%
|
O:
-1.34%
H:
0.0%
C:
0.0%
drug
propel
report
research
global
growing
market
STADA and Alvotech Secure Approval for Uzpruvo, Europe’s First Ustekinumab Biosimilar to Stelara
Published:
2024-01-10
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
5.84%
|
O:
-0.72%
H:
1.77%
C:
-1.53%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-13.93%
|
O:
-0.66%
H:
0.71%
C:
0.17%
first
biosimilar
approval
stelara
Nontuberculous Mycobacterial Infections Market size to grow by USD 4.33 billion from 2023 to 2028, North America to account for 40% of market growth- Technavio
Published:
2024-01-10
(Crawled : 05:00)
- prnewswire.com
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-21.12%
|
O:
1.19%
H:
0.2%
C:
0.03%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-3.02%
|
O:
-0.09%
H:
7.77%
C:
4.4%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.44%
|
O:
0.76%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.81%
|
O:
0.13%
H:
0.0%
C:
0.0%
america
infections
market
MedinCell’s partner Teva Announces Recruitment Completion of Phase 3 Clinical Study of mdc-TJK / Olanzapine Long-Acting Injectable (LAI)
Published:
2024-01-09
(Crawled : 20:00)
- biospace.com/
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
teva
study
Epinephrine Autoinjector Market size to grow by USD 2.44 billion from 2023 to 2028, North America to account for 46% of market growth- Technavio
Published:
2024-01-07
(Crawled : 00:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-6.09%
|
O:
-0.83%
H:
0.72%
C:
-1.43%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
5.98%
|
O:
0.0%
H:
4.27%
C:
2.56%
ABG
|
$215.12
1.72%
0.0%
160K
|
Retail Trade
|
3.45%
|
O:
-1.04%
H:
1.61%
C:
1.44%
america
epinephrine
market
Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio
Published:
2024-01-05
(Crawled : 22:00)
- prnewswire.com
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AAPL
|
News
S
|
$164.96
-1.24%
-1.32%
67M
|
Electronic Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
GOOG
|
News
S
|
$155.7
-1.12%
-1.13%
20M
|
Technology Services
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GOOGL
|
News
S
|
$154.08
-1.24%
-1.25%
32M
|
Technology Services
|
Email alert
Add to watchlist
active
asia
growth
market
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)
Published:
2024-01-03
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
16.37%
|
O:
1.23%
H:
2.17%
C:
1.57%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-15.75%
|
O:
-0.97%
H:
1.53%
C:
0.0%
avt06
eylea
candidate
biosimilar
results
study
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Published:
2024-01-02
(Crawled : 00:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
23.18%
|
O:
0.29%
H:
3.53%
C:
1.91%
conference
year
teva
financial
results
Proton Pump Inhibitors (PPIs) Market to grow by USD 807.89 million from 2023-2028 | North America to account for 36% of market growth - Technavio
Published:
2023-12-19
(Crawled : 07:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.41%
|
O:
3.81%
H:
0.0%
C:
0.0%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
17.91%
|
O:
1.22%
H:
1.88%
C:
0.94%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.44%
|
O:
0.45%
H:
0.0%
C:
0.0%
RDHL
|
$0.4519
7.39%
6.88%
330K
|
Health Technology
|
-63.11%
|
O:
0.82%
H:
8.94%
C:
7.32%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.94%
|
O:
-0.5%
H:
0.99%
C:
0.43%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.38%
|
O:
1.17%
H:
0.67%
C:
-0.09%
america
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.